The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa (HS) […]
Category: News
Approval extends ustekinumab’s use to younger patients
Collaboration introduces automation to enhance efficiency
GMP certification enables 4basebio to supply DNA for clinical trials
Advancing care for stage 3 or 4 Hodgkin lymphoma patients
Collaboration expands AI-based risk profiling tools
New therapy developed to repair GJB2 R75W mutation
Janssen drug combination extends life expectancy during trial
NOUS-209 shows potential to intercept cancer in its early stages
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants